Use of HIV protease inhibiting compounds
US6506555B1 · kind B1 · utility
1Cited by
0References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 19, 2001 |
| Grant date | Jan 14, 2003 |
| Priority date | — |
| Expiry date | Jun 19, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of at least one compound that inhibits HIV (human immunodeficiency virus) protease, selected from ritonavir, saquinavir or one of the pharmaceutically acceptable salts thereof, in association with a pharmaceutically acceptable vehicle for the production of a medicament to modulate proteasome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.